@article{ref1,
title="Prevalence and associations of classic psychedelic-related seizures in a population-based sample",
journal="Drug and alcohol dependence",
year="2022",
author="Simonsson, Otto and Goldberg, Simon B. and Chambers, Richard and Osika, Walter and Long, Dustin M. and Hendricks, Peter S.",
volume="239",
number="",
pages="e109586-e109586",
abstract="OBJECTIVES: Previous studies have reported links between classic psychedelic use and seizures, but little remains known about prevalence and potential risk factors of classic psychedelic-related seizures. <br><br>METHODS: Using a sample representative of the US adult population with regard to sex, age, and ethnicity (N = 2822), this study examined the prevalence and potential risk factors of classic psychedelic-related seizures, in a subsample of respondents who reported lifetime classic psychedelic use (n = 613). <br><br>RESULTS: Among those who reported lifetime classic psychedelic use, 1.5 % reported classic psychedelic-related seizures, a statistic that comports with the prevalence of epilepsy in the US population. Among those who reported seizures while using a classic psychedelic, almost half reported co-use of antidepressants, mood stabilizers, or opioid replacement therapies at the time of the seizures. Notably, classic psychedelic-related seizures were more commonly reported in certain respondents, especially those with a personal or family history of epilepsy. <br><br>CONCLUSIONS: These results suggest that classic psychedelic use could increase the risk of seizures in certain populations, particularly those with a personal or family history of epilepsy.<p /> <p>Language: en</p>",
language="en",
issn="0376-8716",
doi="10.1016/j.drugalcdep.2022.109586",
url="http://dx.doi.org/10.1016/j.drugalcdep.2022.109586"
}